Equity markets started 2025 pretty well, but things haven't been so rosy in the past couple of months. The tech-heavy Nasdaq ...

In the latest quarter, 22 analysts provided ratings for Coinbase Global (NASDAQ:COIN), showcasing a ... Key Insights: Action Taken: In response to dynamic market conditions and company performance ...

The Notice has no immediate effect on the listing or trading of the Company’s ordinary shares on the Nasdaq Global Market. The Notice states that the Company has 60 calendar days, or until April ...

These ratings communicate expectations for the relative performance of S&P Global compared to the broader market. Price Targets: Analysts set price targets as an estimate of a stock's future value.

Zimmer Biomet is diligently working to strengthen its foothold in international developed and emerging markets that provide long-term opportunities for growth. The company's strategic investments ...

Deep-pocketed investors have adopted a bearish approach towards Coinbase Global (NASDAQ:COIN), and it's something market players shouldn't ignore. Our tracking of public options records at ...

Cognition's transfer from The Nasdaq Global Market to The Nasdaq Capital Market suggests a diminished status that may affect investor perception and confidence. The potential need for a reverse ...

For its part, Green Pool Commodity Specialists on February 5 projected that the global sugar market will shift to ... do not necessarily reflect those of Nasdaq, Inc. With headquarters in the ...

Trinity Biotech's stock will continue to trade on the Nasdaq Global Select Market, allowing for potential recovery and investor confidence during the compliance period. The company has a ...

Stocks with high Zacks Ranks and "A" grades for Value will be some of the highest-quality value stocks on the market today. One company to watch right now is MRC Global (MRC). MRC is currently ...

For its part, Green Pool Commodity Specialists on February 5 projected that the global sugar market will shift to a surplus of +2.7 MMT in the 2025/26 crop year from its estimate of a deficit of ...

PURCHASE N.Y., March 12, 2025 (GLOBE NEWSWIRE) -- Cognition Therapeutics, Inc. (Nasdaq: CGTX), a clinical stage company developing product candidates that treat neurodegenerative disorders, (the ...